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that the university’s deficit was
partly due to a 25 per cent
increase in sponsored research in
the past two years. “Research
funding does not cover the total
overhead costs and so the
university is left out of pocket.”
Senior figures have argued that
the new costing strategy will have
to be monitored carefully to
ensure that it does not damage
the research environment it is
designed to protect.
David Wallace, vice-president of
the Royal Society, said: “I fear
that this has been driven by
consultants and accountants who
almost certainly don’t understand
what research is about.”
“Although it didn’t say
academics had to keep
timesheets, it did imply they had
to log time,” he said. “If this kind
of detail was imposed on
academics, it would be a serious
risk to our excellent research
culture.”
In a recent written statement to
the government, UUK took a
similar line, praising the system
but but urging: “Requirements on
institutions to demonstrate their
use of the full economic costing
should be proportionate and not
represent an additional regulatory
burden.”
But a spokesperson for the
Office of Science and Technology
dismissed fears about red tape.
He said academics had always to
write down how much time they
expected to spend on research
projects when they were applying
for funding, adding: “They will not
be audited or policed on it. And
there will be no timesheets.”
Under the new system the
research councils will eventually
be expected to cover the full
costs of the research they fund.
The treasury’s ten-year
investment plan for science,
published last month, included an
extra £80 million to move towards
this goal. Experts in the sector
estimate that the councils should
soon be able to cover about 70
per cent of costs, leaving
universities to find the remaining
30 per cent.
A spokesperson for the
Association of Medical Research
Charities, whose members fund a
substantial proportion of UK
biomedical research as well as
university infrastructure projects,
supported the new proposals but
emphasised that their funding was
quite distinct from that of the
research councils. “Because of
the difference in their cultures and
purpose, charities will not fund
research in the same way as the
research councils, which pay an
agreed percentage of costs.”
Some charities fear that the need
for universities to meet some of
the overhead costs of their project
might lead to a shunning of funds
from the sector. But the
spokesperson believed that
“universities should not see
charity funding as an obstacle or a
problem”.
The government has planned an
extra £90 million to the Higher
Education Funding Councils to
allow universities to support the
cost of charity-funded university
research.
While most universities insist
they will play by the book and
charge for all the costs they
identify, there are fears that a few
might try to undercut their
competitors with artificially low
bids. 
There is a potential problem of
universities putting expensive
people into principal investigator
positions instead of junior staff.
That would mean the junior
person who was going to be co-
principal investigator would no
longer get a foot on the ladder.
The OST said that it was aware
of the anxieties, but it insisted that
it did not want to introduce
regulations to deal with problems
that may never occur.
Problems facing modern
university managements have
been highlighted by a book
published earlier this month by an
academic at Cambridge
University. The university is
phenomenally successful in terms
of research, but, Gillian Evens,
chair of medieval theology and
intellectual history, believes the
management structure of the
university has led to severe
problems.
One of the hopes for the new
scheme is that highly successful
universities such as Cambridge
can be helped to put their
research funding into the black.
This summer’s silly season in
Germany was not what it used to
be. Certainly, there was some
entertainment ranging from
chancellor Schröder and his
fourth wife adopting a Russian
orphan child, through to the
nation-wide wasp infestation, bad
weather, and Olympic medals or
lack thereof, not to mention the
renewed row over orthographical
matters. But some serious
political concerns continued to
pop up, utterly spoiling the
seasonal fun.
The fear of losing out in the
current reforms of the welfare
system drove many people to the
streets. But academic and
research matters have also raised
their head during this summer
season. The constitutional court
toppled the federal law
introducing junior professorships
on the grounds that it violated
state autonomy in educational
matters. And the news that the
British authorities had granted
permission for therapeutic cloning
launched another big bioethics
debate. Germany was just one of
many countries pondering the
research and ethical implications
of that landmark decision.
Among the industrialised
countries, Germany has some of
the most restrictive legislation on
cloning research. As human life is
protected by law from the very
moment when a sperm merges
with an egg cell (no matter
whether this happens in vitro or in
vivo!), any research involving the
destruction of blastocysts is
strictly forbidden. Researchers
may import human embryonic
stem (ES) cells subject to an
individual licence from a national
authority, and only if the cell lines
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Germany, along with many other
countries, is pondering Britain’s
decision to allow a short-term,
limited licence to clone human
embryos for research. Michael
Gross reports.
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were generated before January
1st 2002.
The news from Newcastle, in
northern England, where
researcher Miodrag Stojkovic
obtained the go-ahead for his
project involving therapeutic
cloning, quickly alerted the
German press to the fact that
Stojkovic, his research assistant
wife, and one of his PhD students
are refugees from German
universities, where their current
research would earn them several
years in prison. Others have
moved to Sweden, or even to the
USA, where stem cell research is
barred from federal funding, but at
least not generally forbidden.
Germany’s 25-strong
national ethics council held
a two-day meeting without
coming to an agreement.
While the council is
unanimous in upholding the
ban on reproductive
cloning, the views on
therapeutic cloning range
from total rejection through
to a case-by-case
permission following the
example of the UK
From August 18th to 19th,
Germany's 25-strong national
ethics council held a two-day
meeting without coming to an
agreement. While the council is
unanimous in upholding the ban
on reproductive cloning, the views
on therapeutic cloning range from
total rejection through to a case-
by-case permission following the
example of the UK. The council
announced that it will release a
document including the different
views in September, when the
cloning debate will also be on the
agenda of the UN. The council’s
chairman, law professor Spiros
Simitis, admitted that the council
failed to come up with a
recommendation and suggested
privately that the government
should reintroduce the debate into
parliament. As an opinion poll
commissioned by the news
weekly Der Spiegel shows that
two thirds of the voters are
opposed to following the British
lead, the government has kept its
head down. “There is no majority
for a change of the ban on
cloning,” an official from the
research ministry stated.
Observers tend to assume that
Schröder, who takes pride in his
close relations with industry,
would be in favour of a more
permissive cloning law which
might boost the fledgling German
biotech industry. Similarly, his
research minister, Edelgard
Bulmahn, would probably wish for
such a move, but is currently tied
up in damage limitation following
the defeat in the constitutional
court over university reform. The
justice minister Brigitte Zypries is
so far the only member of the
government who has openly
asked to reconsider whether an
early stage blastocyst does own
the ‘dignity of the human being’
which in the current situation
provides it with the unconditional
protection by the constitution
(Current Biology 2003, 13, R937).
Among the members of the
ethics council, Jens Reich, a
highly regarded former GDR
dissident, has argued that
whatever constructs are
generated by cloning are not good
enough to deserve the
constitutional protection. The
research organisations, including
the Deutsche
Forschungsgemeinschaft (DFG,
the major public funding agency)
have spoken out in favour of
change, but their vote might be
counted as predictable and not
very influential with the parliament
or the wider public.
Meanwhile, those who believe
that Christian morality rules out
any research with human embryos
insist that the current restrictive
legislation should not be touched
or even debated at all. This view is
represented by a theologician in
the ethics council as well as by
some members of the ruling
Green Party and many in the
Christian Democrat opposition. By
and large it appears that the
cross-party majority that inflicted
the current legislation on a
reluctant government is still
holding strong.
Thus, Schröder may have to
wait a little bit longer before he
can throw this controversial topic
into the parliamentary debate
again without risking a crushing
defeat. The trouble is that any
further delay will contribute to the
brain drain and help to slow down
German biotech. On the other
hand, the chancellor will be quite
busy with saving his welfare and
university reforms, and looking
after that orphan child.
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Pondering: Legislators and academics in Germany and elsewhere are considering the
implications of the UK’s decision to allow the limited cloning of human embryos for
research purposes. (Picture: Associated Press.)
